Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

Simple item page
dc.contributor.authorKnuf, Markus
dc.contributor.authorLeroux-Roels, Geert
dc.contributor.authorRümke, Hans C.
dc.contributor.authorAbarca Villaseca, Katia
dc.contributor.authorRivera, Luis
dc.contributor.authorLattanzi, María
dc.contributor.authorPedotti, Paola
dc.contributor.authorArora, Ashwani
dc.contributor.authorKieninger-Baum, Dorothee
dc.contributor.authorDella Cioppa, Giovanni
dc.date.accessioned2020-08-29T00:35:59Z
dc.date.available2020-08-29T00:35:59Z
dc.date.issued2015
dc.format.extent8 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1016/j.vaccine.2014.10.085
dc.identifier.issn0264-410X
dc.identifier.issn1358-8745
dc.identifier.urihttps://doi.org/10.1016/j.vaccine.2014.10.085
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/40584
dc.issue.numeroNo. 1
dc.language.isoen
dc.pagina.final181
dc.pagina.inicio174
dc.revistaVaccinees_ES
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherVirus de la influenza Aes_ES
dc.subject.otherVacuna contra la influenzaes_ES
dc.titleSafety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of agees_ES
dc.typeartículo
dc.volumenVol. 33
sipa.codpersvinculados70281
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Safety and immunogenicity of an MF59 (R)-adjuvanted A H1N1 pandemic influenza vaccine in children from three to seventeen years of age.pdf
Size:
529.03 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas